Thursday, 02 April 2020

Drug Discovery News

  • Agilent LC/MS for 'dried blood-spot analysis'

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2012

    Singapore: Agilent Technologies has introduced the Agilent Automated Card Extraction LC/MS system, a fully integrated instrument for the analysis of dried blood spots and other dried media....Read more

  • AMRI to acquire Cedarburg Pharmaceuticals at $38.2 mn

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2014

    Singapore: AMRI has signed a definitive agreement to acquire all the outstanding shares of Cedarburg Pharmaceuticals for USD38.2 million in cash. The transaction, including USD2.8 million ...Read more

  • Let's make India known for innovations'

    Drug Discovery |  Opinion | By BioSpectrum Bureau  | 0 Comment | 25 Mar, 2014

    As a scientist-turned entrepreneur, my journey has taken a long time, with many struggles along the way. For an entrepreneur every step is a milestone. He must possess a keen eye to identif...Read more

  • Novartis gets FDA approval for chronic idiopathic urticaria drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Mar, 2014

    Singapore: US Food and Drug Administration (FDA) has approved Novartis' Xolair (omalizumab) for the treatment of chronic idiopathic urticaria (CIU), an unpredictable and debilitating skin d...Read more

  • Drug developed in New Zealand gets go ahead for trial

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2012

    Singapore: The US Food and Drug Administration (FDA) has granted approval for PR610, an anticancer "stealth" drug invented in New Zealand, to move forward to human clinical trials through i...Read more

  • FDA approves Merck's Keytruda for advanced lung cancer

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Oct, 2015

    Merck announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA (pembrolizumab)monotherapy, the company's anti-PD-1 (programmed death receptor-1) therapy, at a dose o...Read more

  • AstraZeneca, KHIDI setup cancer research program

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2014

    Singapore: AstraZeneca signed a memorandum of understanding (MoU) with the Korea Health Industry Development Institute (KHIDI) to set up an oncology research programme. AstraZeneca will pro...Read more

  • FDA approves SNDA for BMS-Pfizer DVT prevention drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Mar, 2014

    Singapore: U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug Application (sNDA), co-developed by Bristol-Myers Squibb and Pfizer, for Eliquis (apixaban) for the p...Read more

  • BioPharma Asia: Bionomics wins Innovative Asian Biotech of the Year Award

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 17 Mar, 2014

    Singapore: Australia based Bionomics is recognized as the Innovative Asian Biotech of the Year at BioPharma Asia Industry Awards during the BioPharma Asia Convention, held in Singapore from...Read more

  • Australia approves drug for cystic fibrosis

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2013

    Singapore: US-based Vertex Pharmaceuticals has received Therapeutic Goods Administration (TGA) of Australia approval of KALYDECO (ivacaftor) for people with cystic fibrosis (CF) ages 6 and ...Read more

  • Austrianova's trial data proves efficacy

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Oct, 2012

    Singapore: Singapore-based Austrianova presented additional safety and efficacy data from a second phase II pancreatic cancer clinical trial at the International Society for Cell and Gene T...Read more

  • Genentech skin hive drug shows +ve results

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Feb, 2013

    Singapore: Genentech's omalizumab has shown success in reducing disease severity in patients with moderate to severe chronic idiopathic urticaria (CIU) in phase III trial. CIU, also referr...Read more

  • EU patent for Phylomer ischemia peptides

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Apr, 2013

    Singapore: Phylogica has been granted a new European patent (no. 1793841) entitled: 'Peptide inhibitors of c-Jun dimerization and uses thereof'. This international patent (PCT/AU2005/001255...Read more

  • Thermo Fisher Scientific to support research in NUS

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Apr, 2014

    Singapore: Thermo Fisher Scientific and National University of Singapore (NUS) have entered into a strategic alliance to advance basic and applied research in Singapore for future discoveri...Read more

  • Daiichi Sankyo reports positive results for tivantinib

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2012

    Singapore: Biotech company ArQule and Japan-based Daiichi Sankyo have achieved positive results from a randomized, placebo controlled, double-blind, phase II clinical trial with the selecti...Read more

  • Eisai expands its anti-obesity drug market

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Nov, 2013

    Singapore: Global pharmaceutical firm, Eisai has expanded the marketing and supply agreement between its U.S. subsidiary Eisai Inc. and U.S-based Arena Pharmaceuticals's Swiss subsidiary, A...Read more

  • Merck gets cancer drug license from Symphogen

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

    Singapore: Symphogen signed an exclusive worldwide license agreement with Merck in Germany for Sym004, an investigational antibody mixture targeting the epidermal growth factor receptor (EG...Read more

  • Kinex receives funds from Hong Kong govt ITC

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: US-based Kinex Pharmaceuticals's application for the Small Entrepreneur Research Assistance Programme has been approved by the Innovation and Technology Commission of Hong Kong. ...Read more